Lexicon Pharmaceuticals | LXRX - EPS Earnings Per Share


Lexicon Pharmaceuticals reported $-0.04 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Abbott USD 1.15 0.35 Mar/2026
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Illumina USD 1.15 0.2 Mar/2026
Insmed USD -0.76 0.78 Mar/2026
Ironwood Pharmaceuticals USD 0.24 0.25 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
MacroGenics USD -0.58 0.36 Mar/2026
MannKind USD -0.02 0.03 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Thermo Fisher Scientific USD 5.44 1.13 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024